GF Fund Management’s Centessa Pharmaceuticals CNTA Stock Holding History

GF Fund Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,166	Closed	-$86K	–	597
2026 Q1	$86K	Buy	2,166 +271	+14%	+$6.93K	﹤0.01%	353
2025 Q4	$47.4K	Sell	1,895 -169	-8%	-$4.28K	﹤0.01%	411
2025 Q3	$50.1K	Sell	2,064 -219	-10%	-$3.89K	﹤0.01%	394
2025 Q2	$30K	Hold	2,283	–	–	﹤0.01%	459
2025 Q1	$32.8K	Buy	2,283 +411	+22%	+$6.72K	﹤0.01%	452
2024 Q4	$31.4K	Buy	+1,872	New	+$31K	﹤0.01%	432

GF Fund Management's CNTA Position: Q2 2026 in Review

GF Fund Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 2,166 shares — an estimated $86K sold.

GF Fund Management first reported a position in CNTA in Q4 2024 and held it in 6 quarters. The position peaked at $86K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

GF Fund Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
GF Fund Management sold 2,166 Centessa Pharmaceuticals shares in Q2 2026, an estimated $86K.
GF Fund Management first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 6 quarters.
GF Fund Management's Centessa Pharmaceuticals position peaked at $86K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.